<DOC>
	<DOCNO>NCT01015196</DOCNO>
	<brief_summary>First randomization : After inclusion Use Daunorubicin ( arm D ) Idarubicin ( arm I ) anthracyclin course chemotherapy ( induction , consolidation course ASCT ) Second randomization : After achieve 1st CR : patient receive non intensive consolidation course Familial HLA typing required patient Patients HLA-identical sibling : Patients good prognostic factor ( CBF leukemias , WBC &lt; 30 giga/l diagnosis , 1st CR one induction course ) = arm C : allogeneic stem cell transplantation 1st CR ; receive 2 course intensive consolidation chemotherapy All others patient receive allogeneic transplant For patient age less 51 = arm M : upfront myeloablative conditioning regimen For patient age 51 less 61= arm : intensive chemotherapy consolidation course .</brief_summary>
	<brief_title>Prospective Randomized Study Comparing One Two High Dose Chemotherapy Regimen Followed Autologous Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<criteria>Patients age 15 60 year Diagnosis untreated AML ( FAB 0 2 , 4 7 ) : 20 % marrow blast accord WHO classification Signed informed consent require AML3 subtype Previous diagnosis myelodysplastic syndrome ( MDS ) myeloproliferative disease ; patient previous chemotherapy radiotherapy eligible previous diagnosis MDS Isolated extramedullary disease Inadequate performance status ( ≥ 3 ) , cardiac function ( LVEF &lt; 40 % , severe arythmia unstable coronary disease ) , renal function ( creatininine &gt; 150 µmol/l ) , liver functional test ( bilirubin &gt; 35 µmol/l , liver enzymes &gt; 4 time normal value ) ; life expectancy &lt; 3 month Informed consent refusal</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>acute myeloid leukemia first complete remission</keyword>
</DOC>